Axcelis Technologies (NASDAQ: ACLS) Q1 2026 Results: EPS Beats, But Stock Slides 7%

Axcelis Technologies Inc. (NASDAQ: ACLS) shares fell $12.34 (7.22%) to $158.66 on the session, extending an after-hours decline that followed the company's Q1 2026 earnings release filed with the SEC on May 7, 2026 (8-K, Results of Operations). The report showed adjusted EPS of $0.72 beating the $0.71 consensus by 1.41%, while revenue of $198.956M edged past the $195.029M estimate — a mixed but broadly in-line result that nonetheless failed to satisfy investors.

Q1 2026 At a Glance

• Adjusted EPS: $0.72 vs. $0.71 estimate (+1.41% beat)
• GAAP net income: $9.2 million, or $0.30 per share
• Revenue: $198.956M vs. $195.029M estimate (beat)
• Gross margin: 44.9% | Operating margin: 15.2% | Net margin: 14.3%
• Revenue growth (YoY): -5.6% | EPS growth (YoY): -30.77% (vs. $1.04 in the prior-year period)
• Q2 guidance: Revenue expected above $205.0M (vs. $203.126M consensus); adjusted EPS above $0.90 (vs. $0.82 consensus)
• 52-week range: $52.55 – $171.61 | Market cap: $4.9B

What Drove the Results

The gap between adjusted EPS of $0.72 and GAAP net income of just $0.30 per share reflects meaningful non-cash or one-time items flowing through the income statement during the quarter. Revenue declining 5.6% year-over-year and EPS contracting 28.3% on a trailing basis point to a period of demand normalization in the semiconductor equipment market, consistent with broader industry trends following an investment cycle peak.

Despite the top-line pressure, Axcelis maintained a 44.9% gross margin and a 15.2% operating margin, suggesting the company's cost structure remains relatively disciplined. The Q2 outlook — with guidance above both revenue and EPS consensus — offers a forward signal that management sees conditions stabilizing, though the degree of improvement from Q1 remains modest.

Wall Street View

Analyst sentiment has shifted notably in recent weeks. As of May 1, 2026, the consensus stands at 2 Strong Buy, 5 Buy, 4 Hold, and 1 Sell — a meaningful upgrade from the April 1, 2026 snapshot of just 1 Buy and 6 Hold ratings with no strong conviction on either side. The rotation toward more constructive ratings coincided with a reported 46% monthly rally in the stock ahead of earnings, suggesting some analysts moved to reflect improved near-term visibility.

Investor Takeaway

Axcelis (NASDAQ: ACLS) delivered a quarter that was technically ahead of estimates on both revenue and adjusted EPS, yet the year-over-year declines in revenue (-5.6%) and net income (-28.3%) reflect a business still working through a cyclical correction. Q2 guidance above consensus is a constructive sign, and the significant improvement in analyst buy ratings over the past month suggests growing confidence in a recovery trajectory. Investors will likely look to sequential margin and revenue trends in coming quarters as the key indicators of whether the cycle has genuinely turned.